International Journal of Clinical Research & Trials Volume 5 (2020), Article ID 5:IJCRT-145, 5 pages
https://doi.org/10.15344/2456-8007/2020/145
https://doi.org/10.15344/2456-8007/2020/145
Research Article
Prevalence of Malignancy Among Urban Black Rheumatoid Arthritis Patients
References
- McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365: 2205-2219. [CrossRef] [Google Scholar] [PubMed]
- Baillet A, Gossec L, Carmona L, Wit M, Eijk-Hustings Y et al. (2016) Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis 75: 965-973. [CrossRef] [Google Scholar]
- Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, et al. (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73: 62-68. [CrossRef] [Google Scholar] [PubMed]
- Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A, et al. (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081. [CrossRef] [Google Scholar] [PubMed]
- Isomäki H, Hakulinen T, Joutsenlahti U (1978) Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 31: 691-696. [CrossRef] [Google Scholar] [PubMed]
- De Cock D, Hyrich K (2018) Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management. Best Pract Res Clin Rheumatol 32: 869-886. [CrossRef] [Google Scholar] [PubMed]
- Smitten AL, Simon TA, Hochberg MC, Suissa S (2008) A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 10: 45. [CrossRef] [Google Scholar] [PubMed]
- Cho SK, Lee J, Han M, Bae SC, Sung YK, et al. (2017) The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs. Arthritis Res Ther 19: 277. [CrossRef] [Google Scholar] [PubMed]
- Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 62: 2569-2581. [CrossRef] [Google Scholar] [PubMed]
- Dias EM, Lukas C, Landewé R, Fatenejad S, van der Heijde D, et al. (2008) Reliability and sensitivity to change of the Simple Erosion Narrowing Score compared with the Sharp-van der Heijde method for scoring radiographs in rheumatoid arthritis. Ann Rheum Dis 67: 375-379. [CrossRef] [Google Scholar] [PubMed]
- Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, et al. (2014) Republished: The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Postgrad Med J 90: 722-729. [CrossRef]
- Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, et al. (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70: 482-487. [CrossRef] [Google Scholar] [PubMed]
- Raheel S, Crowson CS, Wright K, Matteson EL, et al. (2016) Risk of malignant neoplasm in patients with incident rheumatoid arthritis 1980–2007 in relation to a comparator cohort: a population-based study. Int J Rheumatol 2016: 4609486. [CrossRef] [Google Scholar] [PubMed]
- Wang YH, Zhang GH, Zhang LL, Luo JL, Gao L, et al. (2018) Clinical characteristic of 74 cases of malignant tumor in rheumatoid arthritis. Beijing Da Xue Xue Bao Yi Xue Ban 50: 986-990. [Google Scholar] [PubMed]
- Smitten AL, Simon TA, Hochberg MC, Suissa S, et al. (2008) A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 10: 45. [CrossRef] [Google Scholar] [PubMed]
- Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S, et al. (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 17: 212. [CrossRef] [Google Scholar] [PubMed]
- Andersen CL, Lindegaard H, Vestergaard H, Siersma VD, Hasselbalch HC, et al. (2014) Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care setting. PLoS One 9: 99388. [CrossRef] [Google Scholar] [PubMed]
- Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, et al. (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76: 960-977. [CrossRef] [Google Scholar] [PubMed]
- Parikh-Patel A, White RH, Allen M, Cress R et al. (2009) Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control 20: 1001-1010. [CrossRef] [Google Scholar] [PubMed]
- Tian G, Liang JN, Wang ZY, Zhou D, et al. (2014) Breast cancer risk in rheumatoid arthritis: an update meta-analysis. Biomed Res Int 2014: 453012. [CrossRef] [Google Scholar] [PubMed]
- Singh N, Gao Y, England BR, Rould P, Field E, et al. (2018) All Site Cancers and Lymphoma Incidence in US Veterans with Rheumatoid Arthritis 2001-2015. Arthritis Rheumatol.
- Baecklund E, Sundström C, Ekbom A, Catrina AI, Biberfeld P, et al. (2003) Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48: 1543-1550. [CrossRef] [Google Scholar] [PubMed]